Could coiling an artery in the head stop migraines?
NCT ID NCT07313800
First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 2 times
Summary
This pilot study tests a procedure called TEMMA, where doctors insert small coils into an artery in the lining of the brain to treat migraine. The study will enroll 25 adults aged 18-60 who have migraine at least 8 days per month and have not gotten relief from at least two preventive medications. Researchers will track changes in headache days, pain intensity, and medication use over 12 months to see if the procedure is safe and provides lasting benefit.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
middle meningeal artery coil embolization (TEMMA procedure using FDA-cleared coils)
What this could lead to
If it works, this could offer a new, lasting treatment option for people with hard-to-treat migraine who haven't responded to medications.
What could go wrong
This is a very early, small pilot study with only 25 people and no control group. The procedure involves risks from angiography and embolization, and it may not reduce migraines for everyone.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MIGRAINE DISORDERS are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Cortex Neurovascular / TRA Union
Tacoma, Washington, 98405, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••